Gene · 51744
CD244: CD244 molecule
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CD244: CD244 molecule. Genes, record 51744. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51744
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BZW8 | Natural killer cell receptor 2B4 | 370 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents102
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4806462 A2 | 2026-09-16 | 40 | Q9BZW8 | Espacenet |
| EP 4795154 A1 | 2026-08-26 | 109 | Q9BZW8 | Espacenet |
| EP 4680651 A1 | 2026-01-21 | 69 | Q9BZW8 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40506 | Q9BZW8 | Espacenet |
| JP 2025541179 A | 2025-12-18 | 126 | Q9BZW8 | Espacenet |
| JP 2025181929 A | 2025-12-11 | 280 | Q9BZW8 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8351 | Q9BZW8 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 462 | Q9BZW8 | Espacenet |
| EP 4641203 A2 | 2025-10-29 | 245 | Q9BZW8 | Espacenet |
| EP 4630459 A1 | 2025-10-15 | 126 | Q9BZW8 | Espacenet |
1 to 10 of 102
See all 102 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,389
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CD244 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 35 | 2025 |
| U19AI082630 | Durable Alteration of the Human Immune system after Infection or Immunotherapy | 22 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 20 | 2025 |
| P01CA111412 | NK cells, their receptors and cancer therapy | 18 | 2025 |
| P01CA065493 | Off-the-Shelf Immune Effector Cells for Hematological Malignancies | 17 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 16 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 11 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 10 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 9 | 2025 |
| T32AI007290 | Molecular and Cellular Immunobiology | 9 | 2025 |
1 to 10 of 2,389Source NIH's project files
See all 2,389 nih grantsPapers3,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface. | Mucosal Immunol | 2026 | 42805341 | PubTator, text mining | PubMed |
| Dual targeting of CD244 and CD2 by a viral-immunoevasin-guided engineered CD48-Fc mutant for T- and NK-cell modulation. | Front Immunol | 2026 | 42746293 | PubTator, text mining | PubMed |
| Could the Immune Modulation of Invariant Natural Killer T Cell and the Expression of CD244 and CD196 on Natural Killer Cell Subtypes Impact the Treatment Outcomes of Acute Myeloid Leukemia Patients? | J Hematol | 2026 | 42730131 | PubTator, text mining | PubMed |
| Impact of Gestational Maternal SARS-CoV-2 Infection on Neonatal Inflammatory Biomarkers. | Am J Reprod Immunol | 2026 | 42640037 | PubTator, text mining | PubMed |
| Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy. | Haematologica | 2026 | 42610426 | PubTator, text mining | PubMed |
| Exploring the Causal Role of Circulating Inflammatory Proteins in Multiple Sclerosis: A Mendelian Randomization Study and Druggability Analysis. | Curr Neurovasc Res | 2026 | 42517387 | PubTator, text mining | PubMed |
| Dual Regulatory Functions and Therapeutic Potential of CD48 in Tumor Immunity. | Oncol Res | 2026 | 42500566 | PubTator, text mining | PubMed |
| CD244 overexpression indicates NK cell dysfunction and tumor progression in diffuse large B-cell lymphoma. | Front Immunol | 2026 | 42483169 | PubTator, text mining | PubMed |
| Inflammatory Cytokines May Mediate the Causal Relationship between Metabolites and Primary Sclerosing Cholangitis: A Bidirectional Mediation Mendelian Randomization Study. | Curr Med Chem | 2026 | 42337887 | PubTator, text mining | PubMed |
| A blueberry-derived polysaccharide inhibits SARS-CoV-2 papain-like protease and exhibits broad-spectrum anti-coronavirus activity. | Nat Prod Res | 2026 | 42262732 | PubTator, text mining | PubMed |
1 to 10 of 3,665
See all 3,665 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51744
GET https://conductscience.org/api/genes/v1/51744/patents?page=2